Key points about Leptospirosis
- Leptospirosis is a bacterial infectious disease transmitted from animals to humans.
- It is contracted through contact with water or soil contaminated by animal urine, most often that of rodents.
- The disease is usually mild but can progress to severe, sometimes fatal forms.
- Early diagnosis and treatment help reduce the risk of complications.
- Prevention relies on individual protection, hygiene and limiting exposure to risk.
What is leptospirosis?
Leptospirosis is a zoonosis caused by bacteria of the genus leptospiraof which there are many types, including Leptospira icterohaemorrhagiae is one of the most frequently implicated in human cases, particularly severe cases. Many animals can be carriers, especially rats which constitute the main reservoirbut also dogs, cattle, or pigs. Infected animals excrete the bacteria in their urine, sometimes for extended periods, without showing symptoms. Transmission to humans occurs during a direct or indirect contact with fresh water, mud, or contaminated soil. The bacteria enter the body through a damaged skin, even minimal, or by the mucous membranes (eyes, mouth). The disease is not not contagious between humans in normal situations. Infections occur more frequently in a context of water recreation,professional activities exposed or after flooding, which promote the spread of the bacteria.
Leptospirosis worldwide
Leptospirosis is present in all regions of the world, with a higher incidence in the areas tropical and subtropicalwhere heat and humidity promote bacterial survival. Globally, it is estimated that approximately 1 million cases occur every year, resulting in nearly 60 deathsThe disease is a significant public health problem in Southeast Asia, Latin America, the Caribbean, and parts of Africa. In temperate countries, including France, leptospirosis is less common but still present, with cases occurring mainly in summer and early autumnOutdoor activities, water sports and certain professions explain some of these infections.
Symptoms of Leptospirosis
Leptospirosis most often begins in a brutal, after an incubation period of a few days to two weeks. The first symptoms are nonspecific and may resemble those of the flu: high fever, chills, headache, intense fatigue et significant muscle pain, particularly in the calves and lower back. nausea, vomiting or an conjunctivitis can also be observed. In the majority of cases, the outcome is favorable. However, in approximately 5 to 10% of infected peoplethe disease progresses towards a severe formThese severe forms, sometimes associated with Leptospira icterohaemorrhagiaeThey can affect several organs. They manifest themselves in particular through a liver damage with jaundice, a renal failure, bleeding (digestive or pulmonary) and, more rarely, severe respiratory involvement. The mortality is generally low, but it can reach 5 to 15% in severe cases. Of sequelae are possible after severe forms, such as persistent kidney failure, liver disorders or prolonged fatigue, sometimes lasting several months.
Diagnosis of Leptospirosis
The diagnosis is based on the combination of suggestive symptoms and a recent risk exposureThis is confirmed by... biological tests, including serological tests or molecular biology techniques (PCR). Further examinations help assess the severity of the illness and guide management. In travelers, migrants, or in cases of late diagnosis, serology is often the gold standard. A follow-up test may be necessary to confirm the recent infection. Additional tests (Blood tests, imaging) may be carried out to assess organ involvement and guide treatment, particularly in severe cases.
Treatment of Leptospirosis
The treatment is based on the administration ofantibioticsThese treatments are all the more effective when started early. Mild cases can be managed on an outpatient basis, while severe cases require [further intervention]. hospitalizationSometimes patients require intensive care, with close monitoring of renal, hepatic, and respiratory functions. Medical follow-up is recommended after the acute phase to verify complete recovery and to screen for any potential long-term effects.
Prevention
A (human) vaccine against leptospirosis is available in France. It only protects against Leptospira questioning of the Icterohaemorrhagiae serogroup. It is recommended for professionals and travellers frequently exposed to potentially contaminated water or environments.
- Exposed professionals : vaccination can be offered on a case-by-case basis by occupational physician after an individual risk assessment of people engaged in professional activities that frequently expose them to potentially contaminated water or environments (for example: maintenance of canals, rivers or banks, work in sewers or certain wastewater treatment plants, fish farming, professional fishing, professional divers, fishery wardens).
- Freshwater travelers and recreation among people going regularly or permanently in areas where leptospirosis is common (tropical or subtropical areas) and engaging in exposed aquatic activities (swimming, canoeing, kayaking, rafting, canyoning, triathlon, hiking in wetlands), vaccination may be offered on a case-by-case basis after individual risk assessment by a healthcare professional.
Vaccination does not protect against all types of leptospires and does not replace personal protective measures (appropriate equipment, hygiene, avoiding contaminated water). It should be considered as a complement to other preventive measures.
FAQ
Leptospirosis is transmitted through direct or indirect contact with fresh water, mud, or soil contaminated by the urine of infected animals, particularly rodents. The bacteria enter the body through even the slightest break in the skin or through mucous membranes. Human-to-human transmission is extremely rare.
The illness usually begins abruptly with a high fever, chills, headaches, intense fatigue, and marked muscle pain, particularly in the calves. Nausea, vomiting, or conjunctivitis may also occur.
In approximately 5 to 10% of cases, leptospirosis progresses to a severe form involving multiple organs, which may include jaundice, kidney failure, hemorrhaging, or respiratory distress. Severe forms occur more frequently after significant exposure or in certain at-risk individuals.
Diagnosis is based on a combination of suggestive clinical signs and recent exposure, confirmed by laboratory tests (PCR or serology). Treatment consists of antibiotic therapy, which is most effective when started early. Severe cases require hospitalization.
Prevention relies on avoiding risky exposures, wearing protective equipment, and adhering to hygiene rules. A vaccine is available in France, protecting against a specific serogroup, and can be offered on a case-by-case basis to professionals or individuals at high risk of exposure. It does not replace personal protective measures.
